Biotechnology company Nanoscope Therapeutics recently announced the formation of Vision Advisory Committee (VAC). 1 VAC is “a group of renowned experts in retina treatment and commercialization,” a ...

Breye Therapeutics announced the successful completion of its phase 1b clinical trial of an oral therapy, danegaptide, for early treatment of non-proliferative diabetic retinopathy (NPDR) and ...

Clinical-stage biotechnology company PYC Therapeutics recently held a type B meeting with the US Food and Drug Administration (FDA) to discuss requirements for a new drug application (NDA) for the ...

Christine Kay, MD, presented interim 1-year data from a phase 1/2 study of an investigational gene therapy (OPGx-LCA5; Opus Genetics) for LCA5-related Leber congenital amaurosis at the Clinical Trials ...

Modern Retina’s recent Case-Based Roundtable focused on next-generation treatments for retinal disease that provide advanced care for neovascular age-related macular degeneration (nAMD) and diabetic ...

Ahead of the Clinical Trials at the Summit (CTS) meeting in Las Vegas, Nevada, Victor Gonzalez, MD, shared an overview of his presentation. Dr. Gonzalez is a trial investigator in the REMAIN follow-up ...

Researchers with the National Institutes of Health (NIH) has identified in a recent study which brain circuits are essential for visual acuity and how they may be affected by retinal cell damage. The ...

The University of Colorado Anschutz Medical Campus’ Department of Ophthalmology has received a $40 million gift. The donor, a patient at the Sue Anschutz-Rodgers Eye Center, has chosen to remain ...

Free diabetic retinopathy (DR) screenings begin this week through a collaboration between Avant Technologies, Ainnova Tech and Grupo Dökka, Fischel Pharmacies and La Bomba Pharmacies, according to a ...

An Indonesian study of the characteristics of the retinal vasculature found that the retinal vessel tortuosity (VT) was significantly higher and the fractal dimension (FD) was significantly lower in ...

Yasha Modi, MD, from NYU Langone Health, New York, New York, and Carl Danzig, MD, from the Rand Eye Institute, Deerfield Beach, Florida, participated in an opinion panel for Modern Retina. They ...

Nassim Abreu, MD, reported the initial experience while applying panretinal photocoagulation (PRP) using the new LYNX pattern laser indirect ophthalmoscope (LIO) (Norlase). Abreu, who is an associate ...